FL

Clinical trials for FL explained in plain language.

Never miss a new study

Get alerted when new FL trials appear

Sign up with your email to follow new studies for FL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New antibody drug shows promise for Hard-to-Treat lymphoma

Disease control Ongoing

This trial tests an antibody called epcoritamab in 666 people with B-cell lymphoma that has come back or not responded to treatment. The drug is designed to help the immune system attack cancer cells. The study looks at safety, the right dose, and how well the drug works.

Matched conditions: FL

Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC

FL

Get alerted when new FL trials appear

New antibody drug shows promise for Hard-to-Treat lymphoma